Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q1

3353.TEDINET S100OPR7
Period2022-03-01 → 2022-05-31
Filed2022-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥8.6bn2022-03-01 → 2022-05-31Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥8.5bn2021-03-01 → 2021-05-31Cons.Net sales
Operating income¥239m2022-03-01 → 2022-05-31Cons.Operating income
Operating income¥303m2021-03-01 → 2021-05-31Cons.Operating income
Ordinary income¥313m2022-03-01 → 2022-05-31Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥316m2021-03-01 → 2021-05-31Cons.Ordinary income
Profit before tax¥334m2022-03-01 → 2022-05-31Cons.Income before income taxes
Profit before tax¥386m2021-03-01 → 2021-05-31Cons.Income before income taxes
Net income (owners)¥208m2022-03-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥226m2021-03-01 → 2021-05-31Cons.Profit loss attributable to owners of parent
Net income¥213m2022-03-01 → 2022-05-31Cons.Profit loss
Net income¥226m2021-03-01 → 2021-05-31Cons.Profit loss
Total assets¥28.8bnat 2022-05-31Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥28.3bnat 2021-05-31Cons.Total assets (5-year summary)
Total liabilities¥16.8bnat 2022-05-31Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.0bnat 2022-05-31Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥10.6bnat 2021-05-31Cons.Net assets (5-year summary)
Cash and deposits¥7.3bnat 2022-05-31Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
EPS (basic)¥55.392022-03-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.092021-03-01 → 2021-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio39.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio37.5%at 2021-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-05-31−¥189m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-05-31¥363m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-05-31¥19m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-05-31¥946m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-05-31¥694m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥252m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-05-31¥16m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥381,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-05-31¥30m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-05-31¥8.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-05-31¥253m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-05-31¥428m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-05-31−¥278m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-05-31−¥278m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-05-31−¥180m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-05-31¥5.8bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-05-31¥5.8bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-05-31¥340m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-05-31¥74m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-05-31¥1.0bn
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-05-31¥726m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥278m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-05-31¥36m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-05-31¥59m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-05-31¥58m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥540,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-05-31¥33m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-05-31¥8.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-05-31¥278m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-05-31¥483m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 353
ItemContextValueUnit
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-44660000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-51814000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-611000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration323000JPY
Other comprehensive incomePrior1YTDDuration-45272000JPY
Other comprehensive incomeCurrentYTDDuration-51490000JPY
Comprehensive incomePrior1YTDDuration180439000JPY
Comprehensive incomeCurrentYTDDuration161596000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration180439000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration156568000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration－JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration5028000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember5754029000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember1968019000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember725690000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember58174000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember8505914000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration8505914000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember150000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember277651000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember540000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember278341000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-278341000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember5754029000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember1968169000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember1003341000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember58714000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember8784256000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-278341000JPY
Net salesPrior1YTDDuration8505914000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember340389000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember74242000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember35502000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember32717000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember482852000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-180336000JPY
Operating incomePrior1YTDDuration302515000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember5872054000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember1948918000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember694022000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember48679000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember8563675000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration8563675000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember150000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember252158000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-05-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-05-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-05-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass